Hcrx

Hcrx is a healthcare royalty acquisition and biopharmaceutical financing firm that provides non-dilutive capital through royalty monetization and corporate financing. It focuses on commercial-stage and near-commercial-stage life sciences assets across biotechnology, pharmaceuticals and medical devices, with debt-oriented financing relevant to companies with healthcare products or royalty streams. Based in New York and investing globally, Hcrx manages about $3 billion in assets and has committed over $7 billion since inception.